U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.
Related Posts
What to Know About Trump’s Order to Phase Out Paper Checks
An executive order from President Trump will require government agencies to make electronic payments for tax refunds, Social Security and other benefits as of Sept. […]
Brian Thompson, Health Insurance Executive, Dies at 50
He was “a truly extraordinary person who touched the lives of countless people,” the chief executive of UnitedHealth Group said.
F.T.C. Sues Largest U.S. Alcohol Distributor for Illegal Pricing
The suit, under a long-dormant antitrust law, accuses Southern Glazer’s of charging small businesses “drastically” more than big chains.